The Clinical Sequencing Evidence-Generating Research (CSER) consortium is a national multi-site research program funded by the National Human Genome Research Institute (NHGRI), the National Cancer Institute (NCI), and the National Institute on Minority Health and Health Disparities (NIMHD) that assesses the effectiveness of integrating genome sequencing into the clinical care of diverse and medically underserved individuals.